Novartis has a much-anticipated approval for its spinal muscular atrophy (SMA) treatment onasemnogene abeparvovec in the US, getting a green light for a new version that can make more patients ...

Tangkap layar video latihan militer Tentara Pembebasan Rakyat China (PLA) dari laman Kementerian Pertahanan China. (ANTARA/HO-Kementerian Pertahanan China.) Beijing (ANTARA) - Latihan militer besar ...

Menteri Kebudayaan Fadli Zon meninjau Museum Cakraningrat di Bangkalan, Madura, Jawa Timur, Senin (22/12/2025). (ANTARA/HO-Kementerian Kebudayaan) Jakarta (ANTARA) - Menteri Kebudayaan Fadli Zon ...

MA Group is expanding its offering for battery energy storage systems (BESS) and large-scale photovoltaic power plants, with the launch on the European market of its new containerized “turnkey” ...

Unified managed accounts (UMAs) and separately managed accounts (SMAs) are two account types that offer high-net-worth clients more control and flexibility than mutual funds. Both options let you ...

Two children with a rare genetic condition will live very different lives because one was tested at birth and the other was not, their parents say. Marley, five, and Meadow, four months, both have ...

Ada kabar bahagia dari Amanda Manopo. Artis pemain film Ikatan Cinta itu dikabarkan hamil. Amanda Manopo mengumumkan terkait kabar kehamilan anak pertama dari sang suami, Kenny Austin, di Instagram.

The FDA has approved onasemnogene abeparvovec-brve (Itvisma, Novartis), an adeno-associated virus vector-based gene therapy for treatment of spinal muscular atrophy (SMA) in patients aged 2 years and ...

Despite possessing a solid data package on the potential of high-dose Sprinraza in spinal muscular atrophy (SMA), Biogen will now need to revise its application if it hopes to secure an FDA nod. The ...

SMA management expects negative one-time losses between €170-220 million. Image: SMA Solar. SMA Solar has forecast financial losses and further restructuring measures in 2025, as it responds to ...

SMA type 3 is a hereditary disease that affects motor neurons. People may also refer to it as Kugelberg-Welander disease. Symptoms usually begin after 18 months of age. Children with SMA type 3 can ...

SMA type 2, previously known as Dubowitz disease, is a hereditary disease that affects motor neurons. It typically becomes noticeable around the ages of 6 to 18 months, when children with the ...